National Research Corporation

NASDAQ:NRC

32.87 (USD) • At close April 18, 2024
Bedrijfsnaam National Research Corporation
Symbool NRC
Munteenheid USD
Prijs 32.87
Beurswaarde 784,094,128
Dividendpercentage 3.75%
52-weken bereik 32.69 - 47.25
Industrie Health Information Services
Sector Healthcare
CEO Mr. Michael D. Hays
Website https://nrchealth.com

An error occurred while fetching data.

Over National Research Corporation

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care

Vergelijkbare Aandelen

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

16.11 USD

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

58.95 USD

Morphic Holding, Inc. logo

Morphic Holding, Inc.

MORF

27.51 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

20.49 USD

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

23.57 USD

Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc.

SANA

7.73 USD

Treace Medical Concepts, Inc. logo

Treace Medical Concepts, Inc.

TMCI

11.27 USD

Cerus Corporation logo

Cerus Corporation

CERS

1.64 USD

Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

ENTA

13.23 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)